Goldman Sachs’s Convey Health Solutions Holdings, Inc. CNVY Stock Holding History

Goldman Sachs’s Portfolio CNVY Stock Details CNVY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-14,865	Closed	-$156K	–	6639
2022 Q3	$156K	Buy	+14,865	New	+$156K	﹤0.01%	5565
2022 Q2	–	Sell	-139,053	Closed	-$910K	–	6891
2022 Q1	$910K	Sell	139,053 -5,793	-4%	-$38.2K	﹤0.01%	4892
2021 Q4	$1.21M	Sell	144,846 -192,465	-57%	-$1.41M	﹤0.01%	4681
2021 Q3	$2.83M	Sell	337,311 -60,044	-15%	-$535K	﹤0.01%	3865
2021 Q2	$4.52M	Buy	+397,355	New	+$4.6M	﹤0.01%	3425

Goldman Sachs's CNVY Position: Q4 2022 in Review

Goldman Sachs sold out of Convey Health Solutions Holdings, Inc. (CNVY) in Q4 2022, closing a stake of 14,865 shares — an estimated $156K sold.

Goldman Sachs first reported a position in CNVY in Q2 2021 and held it in 5 quarters. The position peaked at $4.52M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNVY as of Q4 2022.

Goldman Sachs reported no remaining Convey Health Solutions Holdings, Inc. position as of Q4 2022 after selling out during the quarter.
Goldman Sachs sold 14,865 Convey Health Solutions Holdings, Inc. shares in Q4 2022, an estimated $156K.
Goldman Sachs first reported a position in Convey Health Solutions Holdings, Inc. in Q2 2021 and held it in 5 quarters.
Goldman Sachs's Convey Health Solutions Holdings, Inc. position peaked at $4.52M in Q2 2021.
0 funds tracked by Wall St. Rank held Convey Health Solutions Holdings, Inc. as of Q4 2022.

Based on Goldman Sachs's 13F filing for Q4 2022, filed 13 Feb 2023.